Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REV/O2 appears to be an active wellness and healthcare-adjacent company marketing portable canned oxygen products for consumer use. Its core commercial offering is a 98% pure oxygen canister positioned for altitude support, exercise recovery, focus, and general performance enhancement. The brand markets directly to consumers and emphasizes non-prescription oxygen delivery through a mouthpiece rather than a pharmaceutical or prescription medical model. Based on available public information, it does not appear to operate as a traditional biotech, pharma, or therapeutics developer with a clinical drug pipeline. The requested name "Revo2" most likely refers to the REV/O2 brand rather than an exact legal company name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revo2.